Kitron ASA
Kitron receives EUR 19 million guidance, control and targeting systems order
Kitron receives EUR 19 million guidance, control and targeting systems order
(2025-12-10) Kitron has received an order with an estimated value of EUR 19 million for the production and supply of advanced electronic components used within guidance, control and targeting systems.
The order is an extension of existing business with a long-term defence customer and confirms Kitron’s role as a trusted supplier of mission-critical electronics for advanced weapon systems.
Deliveries under the order are scheduled to start in the second half of 2027, and production will take place at a European Kitron facility.
“This order extension underscores the trust our defence customers place in Kitron’s ability to deliver high-reliability electronics for complex and sensitive applications. It supports the long-term growth ambitions we have communicated within Defence & Aerospace and further strengthens our position in the guidance, control and targeting systems domain,” says Peter Nilsson, President and CEO of Kitron.
For further information, please contact:
Peter Nilsson, President and CEO, tel. +47 948 40 850
Hans Petter Thomassen, VP Central Nordics and North America, tel. +47 913 92 360
Email: investorrelations@kitron.com
Kitron is a leading Scandinavian electronics manufacturing services company for the Connectivity, Electrification, Industry, Medical devices and Defence/Aerospace sectors. The group has operations located in Norway, Sweden, Denmark, Lithuania, Germany, Poland, the Czech Republic, India, Malaysia, China and the United States. Kitron has about 3 000 employees, and revenues were EUR 647 million in 2024.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ProMIS Neurosciences Inc.10.12.2025 13:30:00 CET | Press release
ProMIS Neurosciences Announces New Peer-Reviewed Publication Highlighting Selective Targeting of Toxic Oligomers for Potential Clinical Benefit and Reduced ARIA Risk
Tallink Grupp10.12.2025 13:30:00 CET | Press release
AS Tallink Grupp: Managers’ Transactions
Scatec ASA10.12.2025 13:26:22 CET | Press release
Scatec starts commercial operation at Mmadinare phase 2 in Botswana
Karolinska Development AB (publ)10.12.2025 13:05:37 CET | Press release
Karolinska Development's portfolio company Modus Therapeutics initiates dosing in phase 2a study in patients with chronic kidney disease with anemia
Nykredit Realkredit A/S10.12.2025 12:51:58 CET | Pressemeddelelse
Nykredit Realkredit A/S: Ledende medarbejdere og disses nærtstående transaktioner
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom